Guangdong Marubi Biotechnology Co., Ltd. (603983.SS)
CNY 32.73
(2.22%)
CNY 32.73
(2.22%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -821.24 Million CNY | -2.33% |
| 2022 | -802.56 Million CNY | -2.03% |
| 2021 | -786.62 Million CNY | 49.68% |
| 2020 | -1.56 Billion CNY | 25.62% |
| 2019 | -2.1 Billion CNY | -34.42% |
| 2018 | -1.56 Billion CNY | -41.75% |
| 2017 | -1.1 Billion CNY | -19.78% |
| 2016 | -920.87 Million CNY | -10.39% |
| 2015 | -834.22 Million CNY | -10.24% |
| 2014 | -756.73 Million CNY | -38.82% |
| 2013 | -545.13 Million CNY | -40.89% |
| 2012 | -386.93 Million CNY | -6.43% |
| 2011 | -363.54 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -1.1 Billion CNY | -27.49% |
| 2024 Q2 | -868.32 Million CNY | 3.11% |
| 2024 Q1 | -896.21 Million CNY | -9.13% |
| 2023 Q3 | -604.5 Million CNY | 19.91% |
| 2023 Q2 | -754.78 Million CNY | -0.68% |
| 2023 Q1 | -749.7 Million CNY | 6.59% |
| 2023 FY | -821.24 Million CNY | -2.33% |
| 2023 Q4 | -821.24 Million CNY | -35.85% |
| 2022 FY | -802.56 Million CNY | -2.03% |
| 2022 Q3 | -892.55 Million CNY | 6.39% |
| 2022 Q2 | -953.43 Million CNY | -56.56% |
| 2022 Q1 | -609 Million CNY | 22.58% |
| 2022 Q4 | -802.56 Million CNY | 10.08% |
| 2021 Q4 | -786.62 Million CNY | 43.46% |
| 2021 Q2 | -1.57 Billion CNY | 10.55% |
| 2021 Q1 | -1.75 Billion CNY | -12.31% |
| 2021 FY | -786.62 Million CNY | 49.68% |
| 2021 Q3 | -1.39 Billion CNY | 11.4% |
| 2020 Q3 | -2.01 Billion CNY | 17.58% |
| 2020 Q4 | -1.56 Billion CNY | 22.52% |
| 2020 FY | -1.56 Billion CNY | 25.62% |
| 2020 Q1 | -1.31 Billion CNY | 37.25% |
| 2020 Q2 | -2.44 Billion CNY | -85.61% |
| 2019 Q4 | -2.1 Billion CNY | -14.67% |
| 2019 FY | -2.1 Billion CNY | -34.42% |
| 2019 Q1 | -1.1 Billion CNY | 29.63% |
| 2019 Q3 | -1.83 Billion CNY | -3.75% |
| 2019 Q2 | -1.76 Billion CNY | -60.57% |
| 2018 Q1 | 1.1 Billion CNY | 0.0% |
| 2018 Q4 | -1.56 Billion CNY | 0.0% |
| 2018 FY | -1.56 Billion CNY | -41.75% |
| 2017 FY | -1.1 Billion CNY | -19.78% |
| 2016 FY | -920.87 Million CNY | -10.39% |
| 2015 FY | -834.22 Million CNY | -10.24% |
| 2014 FY | -756.73 Million CNY | -38.82% |
| 2013 FY | -545.13 Million CNY | -40.89% |
| 2012 FY | -386.93 Million CNY | -6.43% |
| 2011 FY | -363.54 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Liuzhou Liangmianzhen Co., Ltd. | -1.19 Billion CNY | 31.159% |
| Shanghai Jahwa United Co., Ltd. | 27.01 Million CNY | 3140.48% |
| Henan Rebecca Hair Products Co., Ltd. | 1.45 Billion CNY | 156.406% |
| Perfect Group Corp., Ltd | 362.74 Million CNY | 326.395% |
| RUNBEN BIOTECHNOLOGY | -239.82 Million CNY | -242.431% |
| Proya Cosmetics Co.,Ltd. | -2.89 Billion CNY | 71.672% |
| Lafang China Co.,Ltd | -1.24 Billion CNY | 33.815% |
| Shanghai Flyco Electrical Appliance Co., Ltd. | -498.49 Million CNY | -64.746% |
| Hangzhou Haoyue Personal Care Co., Ltd | -1.92 Billion CNY | 57.423% |